Positron emission tomography in lung cancer.
Reports on positron emission tomography have become more common in the oncology literature. After a short introduction to positron emission tomography, this review will look at the data relating to the use of this technology in the diagnosis, the staging, and the post-treatment evaluation of patients with lung cancer and will discuss its potential role in these evaluations.
Lowe
V J
VJ
Department of Nuclear Medicine, St. Louis University Health Sciences Center, Missouri, USA. lowe@nucmed.slu.edu
Naunheim
K S
KS
D002283:Carcinoma, Bronchogenic / Q000000981:diagnostic imaging / Q000473:pathology / Q000556:secondary / Q000628:therapy; D005188:False Negative Reactions; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008168:Lung / Q000002:abnormalities / Q000000981:diagnostic imaging; D008175:Lung Neoplasms / Q000000981:diagnostic imaging* / Q000473:pathology / Q000628:therapy; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D009364:Neoplasm Recurrence, Local / Q000000981:diagnostic imaging; D009367:Neoplasm Staging; D019275:Radiopharmaceuticals; D014055:Tomography, Emission-Computed; D016896:Treatment Outcome
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18